Beijing Succeeder Technology Inc.

Shanghai Stock Exchange 688338.SS

Beijing Succeeder Technology Inc. Price to Earnings Ratio (P/E) on January 14, 2025: 20.87

Beijing Succeeder Technology Inc. Price to Earnings Ratio (P/E) is 20.87 on January 14, 2025, a -26.56% change year over year. Price to earnings ratio compares the stock price to earnings per share; higher P/E suggests expectations for future earnings growth.

Beijing Succeeder Technology Inc. 52-week high Price to Earnings Ratio (P/E) is 28.41 on January 15, 2024, which is 36.16% above the current Price to Earnings Ratio (P/E).
Beijing Succeeder Technology Inc. 52-week low Price to Earnings Ratio (P/E) is 17.78 on February 05, 2024, which is -14.78% below the current Price to Earnings Ratio (P/E).
Beijing Succeeder Technology Inc. average Price to Earnings Ratio (P/E) for the last 52 weeks is 21.74.

Key data

Date	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield

Shanghai Stock Exchange: 688338.SS

Beijing Succeeder Technology Inc.

CEO	Mr. Hai Wang
IPO Date	Aug. 6, 2020
Location	China
Headquarters	Tower 1A
Employees	296
Sector	Health Care
Industries Biotechnology Chemicals & Advanced Materials Medical Instruments Pharmaceuticals

Description

Beijing Succeeder Technology Inc. engages in the research and development, manufacture, and sale of in-vitro diagnostic products in China and internationally. Its products include coagulation analyzers and reagents, blood rheology analyzers, ESR analyzers, and platelet aggregation analyzers. The company was founded in 2003 and is headquartered in Beijing, China.

Key trends

Past 5 years